DXR

MKT CAP:$59M

Daxor Corporation

Market Cap

$59M

Healthcare·Medical Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$9.50-$4.86 (-33.84%)

Jun 22, 2026

52W High $14.7552W Low $8.87

Company Details

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical ...

Leadership

Michael Richard Feldschuh

Chairman, President & CEO

Robert J. Michel CPA, M.B.A.

CFO, Chief Compliance Officer & Corporate Secretary

Jonathan Adam Feldschuh

Chief Scientific Officer & Director

John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.

Chief Medical Officer

Linda Cooper

Vice President of Development & Operations

Kathryn A. Kornafel

Senior VP of Marketing & Commercial Development

IPO Date

Mar 17, 1992

Website

www.daxor.com

Key Metrics TTM

Revenue

$917.3K

+281.4% YoY

Net Income

$10M

EPS (Diluted)

Free Cash Flow

-$1M

Revenue / Share

$0.18

Gross Margin

66.1%

Operating Margin

1219.0%

Net Margin

1058.2%

FCF Margin

-133.7%

P/S

63.9x

P/E

6.0x

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding